Ongoing and planned trials of antiplatelet therapy in the acute and long-term management of patients with ischaemic brain syndromes: Setting a new standard of care

Cerebrovascular Diseases

Volumn 17, Issue SUPPL. 3, 2004, Pages 11-16

  Hankey, Graeme J ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Acetylsalicylic acid; Antiplatelet therapy; Atherothrombosis; Clopidogrel; Stroke

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; IRBESARTAN; PLACEBO; SIMVASTATIN; TELMISARTAN; TICLOPIDINE; WARFARIN;

ARTERY THROMBOSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE PLANNING; HEALTH HAZARD; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; INTERNAL CAROTID ARTERY; ISCHEMIC HEART DISEASE; LONG TERM CARE; NEUROPROTECTION; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK REDUCTION; SECONDARY PREVENTION; STANDARD; STROKE; SYMPTOM; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK;

ASPIRIN; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DISEASE MANAGEMENT; HUMANS; PATIENT CARE; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RISK FACTORS; SYNDROME; TIME FACTORS;

EID: 1642455872     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075299     Document Type: Conference Paper

References (19)

1. Lovett JK, Dennis MS, Sandercock PAG, Bamford J, Warlow CP, Rothwell PM: Very early risk of stroke after a first transient ischemic attack. Stroke 2003;34:e138-e142.
2. Antithrombotic Trialists' Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
3. International Stroke Trial Collaborative Group: The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet 1997;349:1569-1581.
4. CAST (Chinese Acute Stroke Trial) Collaborative Group: CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 1997;349:1641-1649.
5. Chen ZM, Sandercock P, Pan HC, Counsell C, Collins R, Liu LS, Xie JX, Warlow C, Peto R, on behalf of the CAST and IST Collaborative Groups: Indications for early aspirin use in acute ischemic stroke. A combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. Stroke 2000;31:1240-1249.
6. Kennedy J, Eliasziw M, Buchan A, on behalf of the FASTER Investigators: The Fast Assessment of Stroke and Transient ischemic attack (TIA) to prevent Early Recurrence (FASTER) trial - pilot phase. 28th International Stroke Conference, Feb 2003, Phoenix. Abstract available at URL: http://www. strokeconference.org/sc_includes/pdfs/CTP24.pdf. Accessed 21 July 2003.
7. Hankey GJ, Sudlow CLM, Dunbabin DW: Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease. Stroke 2000;31:1779-1784.
8. Algra A, van Gijn J, Koudstaal PJ: Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone? J Neurol Neurosurg Psychiatry 1999;66:557-559.
9. Topol EJ, Easton JD, Harrington RA, Amarenco P, Califf RM, Graffagnino C, Davis S, Diener HC, Ferguson J, Fitzgerald D, Granett J, Shuaib A, Koudstaal PJ, Theroux P, Van de Werf F, Sigmon K, Pieper K, Vallee M, Willerson JT, on behalf of the Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion (BRAVO) Trial Investigators: Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. Circulation 2003;108:399-406.
10. Teal PA: Recent clinical trial results with antiplatelet therapy: implications in stroke prevention. Cerebrovasc Dis 2004;17(suppl 3):6-10.
11. The Clopidogrel in Unstable angina to prevent Recurrent Events trial investigators: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
12. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ on behalf of the MATCH Investigators: Management of AThe-rothrombosis with Clopidogrel in High-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): study design and baseline data. Cerebrovasc Dis, in press.
13. Bhatt DL, Topol EJ: Scientific and therapeutic advances in antiplatelet therapy. Nat Rev Drug Discov 2003;2:15-28.
14. Diener H, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A: European Stroke Prevention Study 2: Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.
15. De Schryver EL: Design of ESPRIT: An international randomized trial for secondary prevention after non-disabling cerebral ischaemia of arterial origin. European/Australian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) group. Cerebrovasc Dis 2000;10:147-150.
16. Diener HC: Prevention Regimen For Effectively Avoiding Second Strokes (PRoFESS): Rationale and Design. 12th European Stroke Conference, May 2003, Valencia. Available at URL: http://www.eurostroke.org/ongoing-trials.asp. Accessed 21 July 2003.
17. Donnan GA: Aortic Arch Related Cerebral Hazard (ARCH). 28th International Stroke Conference, Feb 2003, Phoenix. Abstract available at URL: http://www.strokeconference.org/sc_includes/pdfs/CTP2.pdf. Accessed 21 July 2003.
18. Markus H, Ringelstein EB, on behalf of the CARESS Investigators: Rationale and study design of the CARESS (Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic carotid Stenosis) trial. 28th International Stroke Conference, Feb 2003, Phoenix. Available at URL: http://www.strokeconference. org/sc_includes/pdfs/CTP45.pdf. Accessed 21 July 2003.
19. Molloy J, Markus HS: Asymptomatic embolization predicts stroke and TIA risk in patients with carotid artery stenosis. Stroke 1999;30:1440-1443.